The treatments, which exist today, are developed to attempt to remove scaly skin and stop skin cells from continuing to grow aggressively. It is a large market opportunity for sure. It is expected ...
Clinical proof-of-concept in psoriasis patients achieved with a mean percentage reduction in PASI from baseline at 4 weeks of 43.7% in the high dose group compared to 13.3% in the placebo group, with ...
SOUTH SAN FRANCISCO, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- DICE Therapeutics, Inc. (Nasdaq: DICE), a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results